BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31115859)

  • 1. CaMKK2 Signaling in Metabolism and Skeletal Disease: a New Axis with Therapeutic Potential.
    Williams JN; Sankar U
    Curr Osteoporos Rep; 2019 Aug; 17(4):169-177. PubMed ID: 31115859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research Resource: Roles for Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) in Systems Metabolism.
    Marcelo KL; Ribar T; Means CR; Tsimelzon A; Stevens RD; Ilkayeva O; Bain JR; Hilsenbeck SG; Newgard CB; Means AR; York B
    Mol Endocrinol; 2016 May; 30(5):557-72. PubMed ID: 27003444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium/calmodulin-dependent protein kinase kinase 2 regulates hepatic fuel metabolism.
    Stork BA; Dean A; Ortiz AR; Saha P; Putluri N; Planas-Silva MD; Mahmud I; Rajapakshe K; Coarfa C; Knapp S; Lorenzi PL; Kemp BE; Turk BE; Scott JW; Means AR; York B
    Mol Metab; 2022 Aug; 62():101513. PubMed ID: 35562082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of low dietary folate intake with lower CAMKK2 gene methylation, adiposity, and insulin resistance in obese subjects.
    Ramos-Lopez O; Samblas M; Milagro FI; Zulet MA; Mansego ML; Riezu-Boj JI; Martinez JA
    Nutr Res; 2018 Feb; 50():53-62. PubMed ID: 29540272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ca
    Jianfei L; Min W; Chunlai M; Bicui C; Jiming Z; Bin W
    Biochem Pharmacol; 2017 Dec; 146():224-232. PubMed ID: 29038020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Genetic Variation on Human CaMKK2 Regulation by Ca
    O'Brien MT; Oakhill JS; Ling NX; Langendorf CG; Hoque A; Dite TA; Means AR; Kemp BE; Scott JW
    Sci Rep; 2017 Feb; 7():43264. PubMed ID: 28230171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CaMKK2 Suppresses Muscle Regeneration through the Inhibition of Myoblast Proliferation and Differentiation.
    Ye C; Zhang D; Zhao L; Li Y; Yao X; Wang H; Zhang S; Liu W; Cao H; Yu S; Wang Y; Jiang J; Wang H; Li X; Ying H
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27783047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypomorphic CAMKK2 in EA.hy926 endothelial cells causes abnormal transferrin trafficking, iron homeostasis and glucose metabolism.
    Sabbir MG; Taylor CG; Zahradka P
    Biochim Biophys Acta Mol Cell Res; 2020 Oct; 1867(10):118763. PubMed ID: 32485269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CaMKK2 kinase domain interacts with the autoinhibitory region through the N-terminal lobe including the RP insert.
    Kylarova S; Psenakova K; Herman P; Obsilova V; Obsil T
    Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2304-2313. PubMed ID: 30053538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD.
    York B; Li F; Lin F; Marcelo KL; Mao J; Dean A; Gonzales N; Gooden D; Maity S; Coarfa C; Putluri N; Means AR
    Sci Rep; 2017 Sep; 7(1):11793. PubMed ID: 28924233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14-3-3 protein directly interacts with the kinase domain of calcium/calmodulin-dependent protein kinase kinase (CaMKK2).
    Psenakova K; Petrvalska O; Kylarova S; Lentini Santo D; Kalabova D; Herman P; Obsilova V; Obsil T
    Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1612-1625. PubMed ID: 29649512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products and insulin resistance.
    Unoki H; Yamagishi S
    Curr Pharm Des; 2008; 14(10):987-9. PubMed ID: 18473850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using the fluorescent properties of STO-609 as a tool to assist structure-function analyses of recombinant CaMKK2.
    Gerner L; Munack S; Temmerman K; Lawrence-Dörner AM; Besir H; Wilmanns M; Jensen JK; Thiede B; Mills IG; Morth JP
    Biochem Biophys Res Commun; 2016 Jul; 476(2):102-7. PubMed ID: 27178209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The camKK2/camKIV relay is an essential regulator of hepatic cancer.
    Lin F; Marcelo KL; Rajapakshe K; Coarfa C; Dean A; Wilganowski N; Robinson H; Sevick E; Bissig KD; Goldie LC; Means AR; York B
    Hepatology; 2015 Aug; 62(2):505-20. PubMed ID: 25847065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes.
    Eduful BJ; O'Byrne SN; Temme L; Asquith CRM; Liang Y; Picado A; Pilotte JR; Hossain MA; Wells CI; Zuercher WJ; Catta-Preta CMC; Zonzini Ramos P; Santiago AS; Couñago RM; Langendorf CG; Nay K; Oakhill JS; Pulliam TL; Lin C; Awad D; Willson TM; Frigo DE; Scott JW; Drewry DH
    J Med Chem; 2021 Aug; 64(15):10849-10877. PubMed ID: 34264658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy Excess, Glucose Utilization, and Skeletal Remodeling: New Insights.
    Lecka-Czernik B; Rosen CJ
    J Bone Miner Res; 2015 Aug; 30(8):1356-61. PubMed ID: 26094610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGFBP-2 stimulates calcium/calmodulin-dependent protein kinase kinase 2 activation leading to AMP-activated protein kinase induction which is required for osteoblast differentiation.
    Xi G; D'Costa S; Wai C; Xia SK; Cox ZC; Clemmons DR
    J Cell Physiol; 2019 Dec; 234(12):23232-23242. PubMed ID: 31155724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diabetic osteopathy].
    Ilić J; Kovacev B
    Med Pregl; 2005; 58(3-4):147-52. PubMed ID: 16526212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A complete map of the Calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) signaling pathway.
    Najar MA; Rex DAB; Modi PK; Agarwal N; Dagamajalu S; Karthikkeyan G; Vijayakumar M; Chatterjee A; Sankar U; Prasad TSK
    J Cell Commun Signal; 2021 Jun; 15(2):283-290. PubMed ID: 33136287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) inhibitors: a novel approach in small molecule discovery.
    Devasahayam Arokia Balaya R; Chandrasekaran J; Kanekar S; Kumar Modi P; Dagamajalu S; Gopinathan K; Raju R; Prasad TSK
    J Biomol Struct Dyn; 2023; 41(24):15196-15206. PubMed ID: 37029757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.